-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AZ7E3esQb9lp854VL1Xv08mVYytgsGM2Gk0r3O0tPuc4OjwovrKt+zVESMhuDu7t R8Il3RnuacVNEF8Z48Cf/w== 0000912057-00-002621.txt : 20000203 0000912057-00-002621.hdr.sgml : 20000203 ACCESSION NUMBER: 0000912057-00-002621 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991230 ITEM INFORMATION: FILED AS OF DATE: 20000127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGEN INTERNATIONAL INC /DE CENTRAL INDEX KEY: 0000916304 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 942852543 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-23252 FILM NUMBER: 514581 BUSINESS ADDRESS: STREET 1: 16020 INDUSTRIAL DR CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 3019848000 MAIL ADDRESS: STREET 1: 16020 INDUSTRIAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20877 FORMER COMPANY: FORMER CONFORMED NAME: IGEN INC /CA/ DATE OF NAME CHANGE: 19931216 8-K 1 FORM 8-K =============================================================================== SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ---------------- Date of Report (Date of earliest Commission File Number 0-23252 event reported) December 30, 1999 IGEN INTERNATIONAL, INC. (Exact name of registrant) Delaware 94-2852543 (State of organization) (I.R.S. Employer Identification Number) 16020 Industrial Drive, Gaithersburg Maryland 20877 (Address of principal executive offices and zip code) (301) 869-9800 (Registrant's telephone Number) =============================================================================== ITEM 5. OTHER EVENTS On December 30, 1999, the U.S. Court of Appeals for the Fourth Circuit affirmed a preliminary injunction that the U.S. District Court for the District of Maryland had issued against Roche Diagnostics, GmbH, the diagnostics unit of F. Hoffman La Roche. The preliminary injunction, issued in 1998, enjoined Roche from marketing products based on IGEN International, Inc.'s ORIGEN(R) technology to physician office laboratories. The preliminary injunction also required Roche to transfer existing customers to IGEN and to escrow all revenues from physician office laboratory sales pending the final outcome of the lawsuit that IGEN filed against Roche in 1997. The lawsuit, as discussed in more detail in IGEN's Form 10-K for the fiscal year ended March 31, 1999 and Form 10-Q's for the quarters ended June 30, 1999 and September 30, 1999, claims multiple breaches of a 1992 license agreement between IGEN and Roche concerning IGEN's ORIGEN technology. The legal action includes charges that Roche has underreported its royalties and has sold ORIGEN-based systems outside of its licensed field. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IGEN INTERNATIONAL, INC. BY: /s/ George V. Migausky ------------------------------- George V. Migausky Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) Dated: January 27, 2000 -----END PRIVACY-ENHANCED MESSAGE-----